Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

Summary

This proposed study aims to evaluate the efficacy of daily Cannabidiol (CBD) Oil Capsules in treating symptoms of DSM-5 anxiety disorders, using a two-arm, 8-week randomized, placebo-controlled trial in adults aged 21-65 years. The study will also evaluate the relationship between inflammation, anxiety and CBD using biological markers as well as examine the neuro-cognitive effects of CBD treatment.

Timeline

Start

2021-12-15

Primary completion

2023-12-15

Completion

2024-02

Drugs

Indications